Understanding Global Health Funding: Why Source Matters, But Mission Must Come First

Global health interventions require vast financial resources, with ensuring universal access to mental health care alone projected to cost $16 trillion by 2030 (Patel et al., 2022). Funding for healthcare priorities such as universal health coverage, infectious disease prevention, and maternal and child health runs into hundreds of billions of dollars annually (WHO, 2023). Given these financial realities, some global health organisations often rely on funding from governments, pharmaceutical companies, and major global health foundations.

Yet, discussions around funding often raise concerns about maintaining independence, ensuring transparency, and preventing external influence from shaping public health priorities. Some organisations, such as Médecins Sans Frontières (MSF), choose to operate through public donations, citing the need to maintain full control over their work (MSF, 2023). Others, such as Gavi, the Vaccine Alliance, and the Global Fund, work with government and private sector donors while implementing strong governance mechanisms to ensure funding decisions remain aligned with public health needs (Gavi, 2022; Global Fund, 2023).

This article explores why it is essential to understand funding dynamics in global health, how organisations can maintain their mission regardless of their financial sources, and why transparency and accountability must be central to every funding relationship.

Funding Should Support Priorities, Not Dictate Them

One of the biggest concerns surrounding funding in global health is whether financial contributors have a say in determining health priorities. Pharmaceutical companies, for instance, may be more inclined to support medication-based interventions, while some government donors may prioritise issues based on political agendas rather than evidence-based needs.

However, funding does not have to dictate priorities. Organisations must establish clear internal governance structures that ensure funding is used to support their mission, not reshape it. Transparency in how funds are allocated, who is consulted in decision-making, and how projects are monitored can mitigate potential conflicts of interest.

For instance, Gavi’s Independent Review Committee ensures that funding allocations are based on public health impact rather than donor preferences (Gavi, 2022). Similarly, the Global Fund has an independent oversight board to safeguard its grant distribution process (Global Fund, 2023). These examples highlight how organisations can accept funding while remaining committed to their goals.

Transparency as a Non-Negotiable Standard

Global health funding should not be a closed-door process. Organisations must be transparent about their funding sources, decision-making processes, and spending, not just to funders but to the communities they serve.

• Why does transparency matter? It ensures trust and accountability between funders, organisations, and the people who rely on their services.
• Who should be involved? Local communities should be included in funding discussions to ensure interventions align with actual healthcare needs rather than donor-driven priorities.

For example, WHO publishes a detailed breakdown of its budget and earmarked contributions to ensure financial accountability (WHO, 2023). Such practices should be the standard across all global health organisations to reinforce credibility and trust.

Balancing Independence with Financial Sustainability

While independence is a core value for many organisations, financial sustainability is equally critical to long-term impact. Relying solely on public donations is not always feasible, especially when scaling up interventions across multiple regions or responding to global health emergencies.

Instead of viewing funding as a potential risk, organisations should approach it as a strategic partnership where they set the terms to safeguard their independence while securing the resources needed to deliver impact.

Some key strategies include:

• Establishing ethical funding policies that outline how funds can be accepted and used.
• Diversifying funding sources to avoid over-reliance on any single donor.
• Creating independent advisory committees to review funding agreements and ensure alignment with public health priorities.

One example is the Medicines Patent Pool (MPP), which collaborates with pharmaceutical companies to increase access to affordable medicines without compromising its mission of equitable drug pricing (MPP, 2023). This model demonstrates how partnerships can work when ethical standards and transparency are prioritised.

Learning from Organisations That Manage Funding Responsibly

Many global health organisations successfully accept funding while maintaining their integrity through strong governance and clear accountability structures. Some examples include:

• Gavi, the Vaccine Alliance: Works with government and private sector donors but ensures funding is allocated based on public health priorities through an independent review process (Gavi, 2022).
• The Global Fund: Receives 93% of its funding from governments, yet operates independently through strict oversight and a multi-stakeholder governance model (Global Fund, 2023).
• WHO: Despite significant funding from governments and philanthropic organisations, WHO maintains its independence in setting global health policies (WHO, 2023).

These organisations show that it is possible to secure funding without compromising independence, provided that robust transparency, governance, and community accountability are in place.

Conclusion: Ethical, Transparent Funding is Key to Global Health Progress

Global health organisations should not be judged solely on where their funding comes from, but rather on how they use it, how they maintain accountability, and whether they uphold their mission to serve communities equitably. Funding is a necessary tool to scale up healthcare interventions, improve access to essential medicines, and respond to global health crises.

Rather than focusing on whether funding should be accepted, the conversation should shift towards how organisations can manage funding responsibly, stand firm in their priorities, and work transparently with funders and communities alike. Ethical financial partnerships rooted in accountability, governance, and community trust are essential for ensuring that funding serves its true purpose: improving health outcomes for all.

---

References

• Evaluate Pharma (2023). World Preview 2023, Outlook to 2028. Available at: https://www.evaluate.com [Accessed 18 Feb 2025].
• Gavi, the Vaccine Alliance (2022). Donor contributions and funding structure. Available at: https://www.gavi.org [Accessed 18 Feb 2025].
• Gates Foundation (2022). Annual Report 2022. Available at: https://www.gatesfoundation.org [Accessed 18 Feb 2025].
• Global Fund (2023). Financial overview and donor contributions. Available at: https://www.theglobalfund.org [Accessed 18 Feb 2025].
• Lexchin, J., Bero, L.A., Djulbegovic, B. and Clark, O. (2020). ‘Pharmaceutical industry sponsorship and research outcome and quality: systematic review’, BMJ, 356, p.i6770.
• Medicines Patent Pool (2023). Expanding access to lifesaving medicines. Available at: https://www.medicinespatentpool.org [Accessed 18 Feb 2025].
• Médecins Sans Frontières (MSF) (2023). Funding Principles and Independence. Available at: https://www.msf.org [Accessed 18 Feb 2025].
• Patel, V., Saxena, S., Lund, C. et al. (2022). ‘The costs involved in mental health care: A global perspective’, Lancet Global Health, 10(1), pp. 1–5. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8793719/ [Accessed 18 Feb 2025].
• World Health Organization (WHO) (2023). Programme Budget and Funding Sources. Available at: https://www.who.int [Accessed 18 Feb 2025].